OsteoBiologics Inc.

This article was originally published in Start Up

01 Mar 1998

Executive Summary

Until recently, there were no treatments to replace damaged cartilage. OsteoBiologics Inc., spun out of technology licensed from the University of Texas Health Science Center, has developed a resorbable biopolymer that may stand alone to mechanically replace damaged cartilage, or may serve as a biologically friendly scaffolding for cell therapies and techniques involving growth factors.

Already Registered? Sign in to continue reading.

New to Medtech Insight? Start a free trial today!

Table
View full table

Topics

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

Medical Device Strategy Platform Technologies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

MT036994

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

MT036994

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

OsteoBiologics Inc.

Executive Summary

Related Content

Biomaterials: Mechanical Engineering Meets Biology

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert